Timber Pharmaceuticals

$0.9901
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.0299 (-2.93%) As of 8:53 PM UTC today

Why Robinhood?

You can buy or sell TMBR and other stocks, options, and ETFs commission-free!

About TMBR

Timber Pharmaceuticals, Inc. operates as a biopharmaceutical company, which focuses on the development and commercialization of treatments for orphan dermatologic diseases. Its initial focus on developing non-systemic treatments for rare dermatologic diseases, including congenital ichthyosis, tuberous sclerosis complex and localized scleroderma. The company is headquartered in Woodcliff Lake, NJ. The listed name for TMBR is Timber Pharmaceuticals, Inc.

CEO
John Koconis
Employees
3
Headquarters
Woodcliff Lake, New Jersey
Founded
—
Market Cap
13.65M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
9.50M
High Today
$1.04
Low Today
$0.9248
Open Price
$1.04
Volume
4.28M
52 Week High
$12.60
52 Week Low
$0.6651

Collections

TMBR Earnings

-$1.36
-$0.86
-$0.36
$0.14
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Estimated
— per share
Actual
Expected Mar 23, After Hours

You May Also Like

ADXS
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure